| Sign In to gain access to subscriptions and/or personal tools. |
Anticardiolipin and anti-ß2glycoprotein-I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and Spaniards
Department of Medicine, Section of Rheumatology, Louisiana State University Medical Center, New Orleans, LA, USA
Department of Internal Medicine, Section of Rheumatology, Universidad de Antioquia, Medellín, Colombia
Department of Internal Medicine, Systemic and Geriatric Diseases Research Laboratory, Vall d'Hebron Hospital, Barcelona, Spain
Department of Medicine, Section of Rheumatology, Louisiana State University Medical Center, New Orleans, LA, USA We studied the prevalence, isotype distribution, and clinical significance of anticardiolipin (aCL) and anti-ß2glycoprotein I (anti-ß2) antibodies in two populations of patients with systemic lupus erythematosus (SLE), 160 Colombians and 160 Spaniards. All sera were tested in our laboratory by enzyme-linked immunosorbent assay (ELISA) for IgG, IgM, and IgA aCL, as well as IgG and IgM anti-ß2GPI. Positive results for at least 1 of the 3 aCL isotypes were found in 40 Colombians (25%) and 55 Spaniards (34%). IgG aCL was the predominant isotype in both populations. Positive results for at least 1 of the anti-ß2GPI isotypes were found in 34 Colombians (21%) and 29 Spaniards (18%). IgG anti-ß2GPI was the dominant isotype in Colombians, while IgM was predominant in Spaniards. Positivity for anti-ß2GPI in aCL-positive patients was present in 77% in the Colombian group and 50% in the Spaniard group. Among Colombians, IgG aCL and anti-ß2GPI correlated with thrombosis, fetal loss, and thrombocytopenia. Among Spaniards, IgG aCL and IgG anti-ß2GPI correlated with thrombosis, fetal loss, and livedo reticularis. For detecting thrombosis and fetal loss, aCL ELISA was more sensitive than anti-ß2GPI in Spaniards, and anti-ß2GPI ELISA was more specific than aCL in both populations.
Key Words: anticardiolipin antibodies anti-ß2glycoprotein I antibodies antiphospholipid syndrome systemic lupus erythematosus
Lupus, Vol. 8, No. 2,
134-141 (1999) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

